!Sample_title,123,118,103,132,119,133,134,104,121,135,108,109,136,102,122,137,138,139,140,94,110,95,90,141,89,105,106,107,120,78,100,79,72,82,124,91,80,96,73,92,74,97,125,130,142,81,111,98,126,75,113,143,85,76,114,88,112,131,144,127,83,145,93,128,129,77,115,1,21,2,3,22,4,23,24,27,5,25,6,28,7,8,56,57,58,59,35,60,36,37,61,38,39,62,63,40,64,65,50,51,41,42,66,43,67,68,44,45,46,47,48,52,53,29,30,31,32,9,10,11,148,86,99,87,116,84,101,146,147,117,70,12,13,14,26,15,69,54,33,55,16,49,71,17,34,18,19,20
!Sample_geo_accession,GSM1256653,GSM1256654,GSM1256655,GSM1256656,GSM1256657,GSM1256658,GSM1256659,GSM1256660,GSM1256661,GSM1256662,GSM1256663,GSM1256664,GSM1256665,GSM1256666,GSM1256667,GSM1256668,GSM1256669,GSM1256670,GSM1256671,GSM1256672,GSM1256673,GSM1256674,GSM1256675,GSM1256676,GSM1256677,GSM1256678,GSM1256679,GSM1256680,GSM1256681,GSM1256682,GSM1256683,GSM1256684,GSM1256685,GSM1256686,GSM1256687,GSM1256688,GSM1256689,GSM1256690,GSM1256691,GSM1256692,GSM1256693,GSM1256694,GSM1256695,GSM1256696,GSM1256697,GSM1256698,GSM1256699,GSM1256700,GSM1256701,GSM1256702,GSM1256703,GSM1256704,GSM1256705,GSM1256706,GSM1256707,GSM1256708,GSM1256709,GSM1256710,GSM1256711,GSM1256712,GSM1256713,GSM1256714,GSM1256715,GSM1256716,GSM1256717,GSM1256718,GSM1256719,GSM1256720,GSM1256721,GSM1256722,GSM1256723,GSM1256724,GSM1256725,GSM1256726,GSM1256727,GSM1256728,GSM1256729,GSM1256730,GSM1256731,GSM1256732,GSM1256733,GSM1256734,GSM1256735,GSM1256736,GSM1256737,GSM1256738,GSM1256739,GSM1256740,GSM1256741,GSM1256742,GSM1256743,GSM1256744,GSM1256745,GSM1256746,GSM1256747,GSM1256748,GSM1256749,GSM1256750,GSM1256751,GSM1256752,GSM1256753,GSM1256754,GSM1256755,GSM1256756,GSM1256757,GSM1256758,GSM1256759,GSM1256760,GSM1256761,GSM1256762,GSM1256763,GSM1256764,GSM1256765,GSM1256766,GSM1256767,GSM1256768,GSM1256769,GSM1256770,GSM1256771,GSM1256772,GSM1256773,GSM1256774,GSM1256775,GSM1256776,GSM1256777,GSM1256778,GSM1256779,GSM1256780,GSM1256781,GSM1256782,GSM1256783,GSM1256784,GSM1256785,GSM1256786,GSM1256787,GSM1256788,GSM1256789,GSM1256790,GSM1256791,GSM1256792,GSM1256793,GSM1256794,GSM1256795,GSM1256796,GSM1256797,GSM1256798,GSM1256799,GSM1256800
!Sample_status,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014,Public on Oct 01 2014
!Sample_submission_date,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013,Nov 01 2013
!Sample_last_update_date,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014,Oct 01 2014
!Sample_type,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA,RNA
!Sample_channel_count,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1
!Sample_source_name_ch1,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Severity Not Available,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Severity Not Available,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Minimal/Mild,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Endometriosis_Moderate/Severe,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology,Non-Endometriosis_No Uterine Pelvic Pathology
!Sample_organism_ch1,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens,Homo sapiens
!Sample_characteristics_ch1,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Unknown,tissue: Early Secretory Endometrial tissue,tissue: Unknown,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Late Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Early Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Late Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Mid-Secretory Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue,tissue: Proliferative Endometrial tissue
!Sample_characteristics_ch1,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis,endometriosis/no endometriosis: Non-Endometriosis
!Sample_characteristics_ch1,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Minimal/Mild,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,endometriosis severity: Moderate/Severe,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology,presence or absence of uterine/pelvic pathology: No Uterine Pelvic Pathology
!Sample_molecule_ch1,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA,total RNA
!Sample_extract_protocol_ch1,"Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix).","Total RNA was isolated from endometrial tissue using Trizol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer‚Äôs instructions, followed by DNase treatment and purification with Qiagen RNeasy Plus Kit. The purity and quality of the RNA were assessed with Agilent 2100 Bioanalyzer. First and second strand cDNAs were prepared according to the Affymetrix microarray preparation protocol (Affymetrix)."
!Sample_label_ch1,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin,Biotin
!Sample_label_protocol_ch1,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.,Biotinylated-cRNA was then prepared using the Ambion MessageAmp II-Biotin Enhanced Kit according to manufacturer instructions.
!Sample_taxid_ch1,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606,9606
!Sample_hyb_protocol,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility,Fragmented biotinylated cRNAs were hybridized overnight to a high density Affimetrix Human Genome (HG) U133 Plus 2.0 oligonucleotide microarray genechip containing 54600 probe sets (42203 annotated genes and 12397 expressed sequence tags [EST]) at the Gladstone Genomics Core Facility
!Sample_scan_protocol,"Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software.","Fluorescent labeling and laser confocal scanning with a GeneChip Scanner 3000. Generated data were extracted for analysis using the Affymetrix Gene-Chip Operating Software and Microsoft Corp. (Redmond, WA) Excel/Mac2001 software."
!Sample_description,SAMPLE 1,SAMPLE 2,SAMPLE 3,SAMPLE 4,SAMPLE 5,SAMPLE 6,SAMPLE 7,SAMPLE 8,SAMPLE 9,SAMPLE 10,SAMPLE 11,SAMPLE 12,SAMPLE 13,SAMPLE 14,SAMPLE 15,SAMPLE 16,SAMPLE 17,SAMPLE 18,SAMPLE 19,SAMPLE 20,SAMPLE 21,SAMPLE 22,SAMPLE 23,SAMPLE 24,SAMPLE 25,SAMPLE 26,SAMPLE 27,SAMPLE 28,SAMPLE 29,SAMPLE 30,SAMPLE 31,SAMPLE 32,SAMPLE 33,SAMPLE 34,SAMPLE 35,SAMPLE 36,SAMPLE 37,SAMPLE 38,SAMPLE 39,SAMPLE 40,SAMPLE 41,SAMPLE 42,SAMPLE 43,SAMPLE 44,SAMPLE 45,SAMPLE 46,SAMPLE 47,SAMPLE 48,SAMPLE 49,SAMPLE 50,SAMPLE 51,SAMPLE 52,SAMPLE 53,SAMPLE 54,SAMPLE 55,SAMPLE 56,SAMPLE 57,SAMPLE 58,SAMPLE 59,SAMPLE 60,SAMPLE 61,SAMPLE 62,SAMPLE 63,SAMPLE 64,SAMPLE 65,SAMPLE 66,SAMPLE 67,SAMPLE 68,SAMPLE 69,SAMPLE 70,SAMPLE 71,SAMPLE 72,SAMPLE 73,SAMPLE 74,SAMPLE 75,SAMPLE 76,SAMPLE 77,SAMPLE 78,SAMPLE 79,SAMPLE 80,SAMPLE 81,SAMPLE 82,SAMPLE 83,SAMPLE 84,SAMPLE 85,SAMPLE 86,SAMPLE 87,SAMPLE 88,SAMPLE 89,SAMPLE 90,SAMPLE 91,SAMPLE 92,SAMPLE 93,SAMPLE 94,SAMPLE 95,SAMPLE 96,SAMPLE 97,SAMPLE 98,SAMPLE 99,SAMPLE 100,SAMPLE 101,SAMPLE 102,SAMPLE 103,SAMPLE 104,SAMPLE 105,SAMPLE 106,SAMPLE 107,SAMPLE 108,SAMPLE 109,SAMPLE 110,SAMPLE 111,SAMPLE 112,SAMPLE 113,SAMPLE 114,SAMPLE 115,SAMPLE 116,SAMPLE 117,SAMPLE 118,SAMPLE 119,SAMPLE 120,SAMPLE 121,SAMPLE 122,SAMPLE 123,SAMPLE 124,SAMPLE 125,SAMPLE 126,SAMPLE 127,SAMPLE 128,SAMPLE 129,SAMPLE 130,SAMPLE 131,SAMPLE 132,SAMPLE 133,SAMPLE 134,SAMPLE 135,SAMPLE 136,SAMPLE 137,SAMPLE 138,SAMPLE 139,SAMPLE 140,SAMPLE 141,SAMPLE 142,SAMPLE 143,SAMPLE 144,SAMPLE 145,SAMPLE 146,SAMPLE 147,SAMPLE 148
!Sample_data_processing,"We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model.","We imported all of the microarray data files into R and normalized them simultaneously. The normalization procedure consists of two steps executed with programs in the Bioconductor package GCRMA. First, we compute the probe affinities using the annotation file hgu133plus2cdf. Second, we normalize the data by setting two options and leaving the rest at default values. The affinity.info option is set to use the probe affinities computed in the first step. The type option is set to fullmodel which uses both the sequence information and mismatch probe model."
!Sample_platform_id,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570,GPL570
!Sample_contact_name,"Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice","Linda,,Giudice"
!Sample_contact_email,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu,giudice@obgyn.ucsf.edu
!Sample_contact_phone,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039,415-476-2039
!Sample_contact_laboratory,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab,Giudice Lab
!Sample_contact_department,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS,OBGYN and RS
!Sample_contact_institute,"University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco","University of California, San Francisco"
!Sample_contact_address,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619,513 Parnassus Ave. HSE 1619
!Sample_contact_city,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco,San Francisco
!Sample_contact_state,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA
!Sample_contact_zip/postal_code,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122,94122
!Sample_contact_country,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA,USA
!Sample_supplementary_file,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256653/suppl/GSM1256653_123.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256654/suppl/GSM1256654_118.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256655/suppl/GSM1256655_103.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256656/suppl/GSM1256656_132.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256657/suppl/GSM1256657_119.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256658/suppl/GSM1256658_133.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256659/suppl/GSM1256659_134.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256660/suppl/GSM1256660_104.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256661/suppl/GSM1256661_121.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256662/suppl/GSM1256662_135.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256663/suppl/GSM1256663_108.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256664/suppl/GSM1256664_109.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256665/suppl/GSM1256665_136.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256666/suppl/GSM1256666_102.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256667/suppl/GSM1256667_122.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256668/suppl/GSM1256668_137.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256669/suppl/GSM1256669_138.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256670/suppl/GSM1256670_139.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256671/suppl/GSM1256671_140.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256672/suppl/GSM1256672_94.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256673/suppl/GSM1256673_110.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256674/suppl/GSM1256674_95.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256675/suppl/GSM1256675_90.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256676/suppl/GSM1256676_141.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256677/suppl/GSM1256677_89.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256678/suppl/GSM1256678_105.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256679/suppl/GSM1256679_106.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256680/suppl/GSM1256680_107.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256681/suppl/GSM1256681_120.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256682/suppl/GSM1256682_78.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256683/suppl/GSM1256683_100.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256684/suppl/GSM1256684_79.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256685/suppl/GSM1256685_72.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256686/suppl/GSM1256686_82.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256687/suppl/GSM1256687_124.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256688/suppl/GSM1256688_91.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256689/suppl/GSM1256689_80.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256690/suppl/GSM1256690_96.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256691/suppl/GSM1256691_73.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256692/suppl/GSM1256692_92.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256693/suppl/GSM1256693_74.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256694/suppl/GSM1256694_97.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256695/suppl/GSM1256695_125.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256696/suppl/GSM1256696_130.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256697/suppl/GSM1256697_142.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256698/suppl/GSM1256698_81.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256699/suppl/GSM1256699_111.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256700/suppl/GSM1256700_98.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256701/suppl/GSM1256701_126.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256702/suppl/GSM1256702_75.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256703/suppl/GSM1256703_113.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256704/suppl/GSM1256704_143.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256705/suppl/GSM1256705_85.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256706/suppl/GSM1256706_76.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256707/suppl/GSM1256707_114.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256708/suppl/GSM1256708_88.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256709/suppl/GSM1256709_112.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256710/suppl/GSM1256710_131.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256711/suppl/GSM1256711_144.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256712/suppl/GSM1256712_127.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256713/suppl/GSM1256713_83.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256714/suppl/GSM1256714_145.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256715/suppl/GSM1256715_93.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256716/suppl/GSM1256716_128.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256717/suppl/GSM1256717_129.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256718/suppl/GSM1256718_77.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256719/suppl/GSM1256719_115.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256720/suppl/GSM1256720_1.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256721/suppl/GSM1256721_21.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256722/suppl/GSM1256722_2.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256723/suppl/GSM1256723_3.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256724/suppl/GSM1256724_22.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256725/suppl/GSM1256725_4.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256726/suppl/GSM1256726_23.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256727/suppl/GSM1256727_24.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256728/suppl/GSM1256728_27.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256729/suppl/GSM1256729_5.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256730/suppl/GSM1256730_25.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256731/suppl/GSM1256731_6.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256732/suppl/GSM1256732_28.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256733/suppl/GSM1256733_7.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256734/suppl/GSM1256734_8.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256735/suppl/GSM1256735_56.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256736/suppl/GSM1256736_57.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256737/suppl/GSM1256737_58.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256738/suppl/GSM1256738_59.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256739/suppl/GSM1256739_35.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256740/suppl/GSM1256740_60.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256741/suppl/GSM1256741_36.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256742/suppl/GSM1256742_37.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256743/suppl/GSM1256743_61.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256744/suppl/GSM1256744_38.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256745/suppl/GSM1256745_39.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256746/suppl/GSM1256746_62.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256747/suppl/GSM1256747_63.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256748/suppl/GSM1256748_40.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256749/suppl/GSM1256749_64.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256750/suppl/GSM1256750_65.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256751/suppl/GSM1256751_50.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256752/suppl/GSM1256752_51.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256753/suppl/GSM1256753_41.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256754/suppl/GSM1256754_42.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256755/suppl/GSM1256755_66.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256756/suppl/GSM1256756_43.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256757/suppl/GSM1256757_67.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256758/suppl/GSM1256758_68.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256759/suppl/GSM1256759_44.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256760/suppl/GSM1256760_45.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256761/suppl/GSM1256761_46.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256762/suppl/GSM1256762_47.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256763/suppl/GSM1256763_48.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256764/suppl/GSM1256764_52.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256765/suppl/GSM1256765_53.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256766/suppl/GSM1256766_29.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256767/suppl/GSM1256767_30.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256768/suppl/GSM1256768_31.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256769/suppl/GSM1256769_32.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256770/suppl/GSM1256770_9.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256771/suppl/GSM1256771_10.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256772/suppl/GSM1256772_11.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256773/suppl/GSM1256773_148.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256774/suppl/GSM1256774_86.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256775/suppl/GSM1256775_99.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256776/suppl/GSM1256776_87.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256777/suppl/GSM1256777_116.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256778/suppl/GSM1256778_84.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256779/suppl/GSM1256779_101.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256780/suppl/GSM1256780_146.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256781/suppl/GSM1256781_147.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256782/suppl/GSM1256782_117.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256783/suppl/GSM1256783_70.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256784/suppl/GSM1256784_12.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256785/suppl/GSM1256785_13.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256786/suppl/GSM1256786_14.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256787/suppl/GSM1256787_26.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256788/suppl/GSM1256788_15.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256789/suppl/GSM1256789_69.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256790/suppl/GSM1256790_54.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256791/suppl/GSM1256791_33.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256792/suppl/GSM1256792_55.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256793/suppl/GSM1256793_16.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256794/suppl/GSM1256794_49.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256795/suppl/GSM1256795_71.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256796/suppl/GSM1256796_17.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256797/suppl/GSM1256797_34.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256798/suppl/GSM1256798_18.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256799/suppl/GSM1256799_19.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1256nnn/GSM1256800/suppl/GSM1256800_20.CEL.gz
!Sample_data_row_count,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675,54675